Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†.

导出原文传递

翻译打印收藏纠错

作者： H,Ghesquieres ^[1] ; M,Chevrier ^[2] ; M,Laadhari ^[3] ; O,Chinot ^[4] ; S,Choquet ^[5] ; C,Moluçon-Chabrot ^[6] ; P,Beauchesne ^[7] ; R,Gressin ^[8] ; F,Morschhauser ^[9] ; A,Schmitt ^[10] ; E,Gyan ^[11] ; K,Hoang-Xuan ^[12] ; E,Nicolas-Virelizier ^[13] ; N,Cassoux ^[14] ; V,Touitou ^[15] ; M,Le Garff-Tavernier ^[16] ; A,Savignoni ^[2] ; I,Turbiez ^[2] ; V,Soumelis ^[17] ; C,Houillier ^[12] ; C,Soussain ^[18]

作者单位： Department of Hematology, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Pierre-Bénite; Department of Hematology, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon. ^[1] Departments of Biostatistics, Aix Marseille University, AP-HM, Marseille. ^[2] Radiology, Institut Curie, Saint-Cloud, Aix Marseille University, AP-HM, Marseille. ^[3] Department of Neuro-Oncology, Hôpital de la Timone, Aix Marseille University, AP-HM, Marseille. ^[4] Department of Hematology, Groupe Hospitalier Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris. ^[5] Department of Hematology, CHU Clermont Ferrand, Clermond Ferrand. ^[6] Department of Neuro-Oncology, CHU Nancy, Nancy. ^[7] Department of Hematology, CHU La Tronche, Grenoble. ^[8] Department of Hematology, Centre Hospitalier Universitaire, Université de Lille, Lille. ^[9] Department of Hematology, Institut Bergonié, Bordeaux. ^[10] Department of Hematology and Cellular Therapy, CIC INSERM U1517, Centre Hospitalier Universitaire, Université de Tours, Tours. ^[11] Department of Neurology 2 Mazarin, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne University, IHU, ICM, Paris. ^[12] Department of Hematology, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon. ^[13] Department of Ophthalmology, Institut Curie - Site Paris, Paris. ^[14] Department of Ophthalmology, Hôpital Pitié Salpetrière, Université Pierre et Marie Curie, Paris. ^[15] Groupe Hospitalier Pitié-Salpétrière, Biological Hematology, Paris, France; Paris University Sorbonne UPMC, INSERM UMRS 1138, Paris. ^[16] Clinical Immunology Laboratory, Department of Biopathology, INSERM U932, Immunity and Cancer, Institut Curie, Paris. ^[17] Department of Hematology, Institut Curie, Saint-Cloud, France. Electronic address: carole.sousain@curie.fr. ^[18]

关键词 lenalidomide primary CNS lymphoma primary vitreoretinal lymphoma relapse rituximab